Aptamer for chymase, and use thereof

Details for Australian Patent Application No. 2010259549 (hide)

Owner Ribomic Inc. Otsuka Pharmaceutical Co., Ltd.

Inventors Nakamura, Yoshikazu; Jin, Ling; Yamazaki, Satoko; Ikeda, Hisako; Muraguchi, Masahiro

Agent Griffith Hack

Pub. Number AU-A-2010259549

PCT Pub. Number WO2010/143714

Priority 2009-140585 11.06.09 JP

Filing date 11 June 2010

Wipo publication date 16 December 2010

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 19/04 (2006.01) Drugs for skeletal disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2010/143714 Priority application(s): WO2010/143714

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010259570-Method for producing 4-substituted benzothioamide derivative

2010259548-Novel protein and gene that codes therefor